NO20034667L - Arylsulfonamider som antivirale midler - Google Patents

Arylsulfonamider som antivirale midler

Info

Publication number
NO20034667L
NO20034667L NO20034667A NO20034667A NO20034667L NO 20034667 L NO20034667 L NO 20034667L NO 20034667 A NO20034667 A NO 20034667A NO 20034667 A NO20034667 A NO 20034667A NO 20034667 L NO20034667 L NO 20034667L
Authority
NO
Norway
Prior art keywords
sup
arylsulfonamides
antivirals
substituents
processes
Prior art date
Application number
NO20034667A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034667D0 (no
Inventor
Tobias Wunberg
Wolfgang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Joerg Keldenich
Armin Kern
Siegfried Raddatz
Juergen Reefschlaeger
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20034667D0 publication Critical patent/NO20034667D0/no
Publication of NO20034667L publication Critical patent/NO20034667L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20034667A 2001-04-19 2003-10-17 Arylsulfonamider som antivirale midler NO20034667L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (2)

Publication Number Publication Date
NO20034667D0 NO20034667D0 (no) 2003-10-17
NO20034667L true NO20034667L (no) 2003-12-12

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034667A NO20034667L (no) 2001-04-19 2003-10-17 Arylsulfonamider som antivirale midler

Country Status (20)

Country Link
US (1) US7115612B2 (es)
EP (1) EP1383749B1 (es)
JP (1) JP4480941B2 (es)
CN (1) CN1516695A (es)
AT (1) ATE308529T1 (es)
BG (1) BG108272A (es)
BR (1) BR0209054A (es)
CA (1) CA2444123C (es)
DE (1) DE50204780D1 (es)
EE (1) EE200300515A (es)
ES (1) ES2252455T3 (es)
HU (1) HUP0303813A3 (es)
IL (1) IL158324A0 (es)
MX (1) MXPA03009548A (es)
NO (1) NO20034667L (es)
PL (1) PL363990A1 (es)
RU (1) RU2003133750A (es)
SK (1) SK12662003A3 (es)
UY (1) UY27263A1 (es)
WO (1) WO2002085869A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494164A1 (en) * 2002-08-23 2004-03-04 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
SI3889142T1 (sl) 2003-04-11 2022-10-28 Ptc Therapeutics, Inc. Spojine 1,2,4-oksadiazol benzojske kisline in njihova uporaba za zatiranje nesmiselne ter zdravljenje bolezni
DE102006009928A1 (de) 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
SG170819A1 (en) 2006-03-30 2011-05-30 Ptc Therapeutics Inc Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
JP2010531850A (ja) * 2007-07-02 2010-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規化合物
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
BR112012033411A2 (pt) * 2010-06-28 2015-09-15 Bayer Ip Gmbh compostos heterocíclicos como pesticidas
EP2593434A1 (en) 2010-07-16 2013-05-22 Purdue Pharma LP Pyridine compounds as sodium channel blockers
US9206127B2 (en) 2012-03-16 2015-12-08 Purdue Pharm, L.P. Substituted pyridines as sodium channel blockers
EP2914591B1 (en) * 2012-11-03 2017-10-11 Boehringer Ingelheim International GmbH Inhibitors of cytomegalovirus
WO2014070979A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
US9873677B2 (en) 2014-03-06 2018-01-23 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
WO2016128541A1 (en) * 2015-02-13 2016-08-18 Azienda Ospedaliera Universitaria Senese Human helicase ddx3 inhibitors as therapeutic agents
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
AU765203B2 (en) * 1999-04-19 2003-09-11 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
SK12662003A3 (sk) 2004-04-06
UY27263A1 (es) 2002-11-29
JP2004531536A (ja) 2004-10-14
BG108272A (bg) 2004-10-29
CA2444123C (en) 2010-09-21
PL363990A1 (en) 2004-11-29
US7115612B2 (en) 2006-10-03
HUP0303813A3 (en) 2005-05-30
EP1383749B1 (de) 2005-11-02
RU2003133750A (ru) 2005-05-10
IL158324A0 (en) 2004-05-12
HUP0303813A2 (hu) 2004-03-29
EP1383749A1 (de) 2004-01-28
JP4480941B2 (ja) 2010-06-16
ATE308529T1 (de) 2005-11-15
DE50204780D1 (de) 2005-12-08
ES2252455T3 (es) 2006-05-16
US20040176374A1 (en) 2004-09-09
NO20034667D0 (no) 2003-10-17
MXPA03009548A (es) 2004-05-24
EE200300515A (et) 2004-02-16
CN1516695A (zh) 2004-07-28
BR0209054A (pt) 2004-04-20
CA2444123A1 (en) 2002-10-31
WO2002085869A1 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20034667L (no) Arylsulfonamider som antivirale midler
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
DK1200418T3 (da) Nematodicide trifluorbutener
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
ATE365740T1 (de) Substituierte pyrazolopyrimidine
NO20054787D0 (no) Indenderivater som farmasotiske midler
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
MXPA02011370A (es) Iminoazinas substituidas.
ATE300541T1 (de) Pyrazolopyridinderivate
SE0101038D0 (sv) Novel compounds
ATE297903T1 (de) Substituierte phenyluracile
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
ATE274515T1 (de) Pyrazolopyridinderivate
HRP20010798B1 (en) Processes for preparing pesticidal intermediates
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
BR0311590A (pt) Agonistas de brs-3 não-peptìdicos
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
ATE374751T1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
CA2425368A1 (en) New sulphoxybenzamides
ATE491709T1 (de) Pyrrolidinohydrochinazoline

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application